Group One Trading
EVOK

Group One Trading’s Evoke Pharma EVOK Stock Holding History

Group One Trading’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28
Closed -$1K – 7468
2022
Q3 		$1K Sell
28
-34
-55% -$1.12K ﹤0.01% 7300
2022
Q2 		$2K Buy
+62
New +$2.96K ﹤0.01% 7396
2022
Q1 		– Sell
-27
Closed -$2K – 8205
2021
Q4 		$2K Sell
27
-103
-79% -$14.4K ﹤0.01% 7867
2021
Q3 		$24K Sell
130
-39
-23% -$6.58K ﹤0.01% 7058
2021
Q2 		$33K Buy
169
+57
+51% +$12.2K ﹤0.01% 6889
2021
Q1 		$29K Sell
112
-128
-53% -$51.2K ﹤0.01% 6573
2020
Q4 		$89K Buy
240
+195
+433% +$101K ﹤0.01% 4655
2020
Q3 		$30K Buy
+45
New +$28.7K ﹤0.01% 4932

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Group One Trading's EVOK Position: Q4 2022 in Review

Group One Trading sold out of Evoke Pharma (EVOK) in Q4 2022, closing a stake of 28 shares — an estimated $1K sold.

Group One Trading first reported a position in EVOK in Q3 2020 and held it in 8 quarters. The position peaked at $89K in Q4 2020. 11 funds tracked by Wall St. Rank hold EVOK as of Q4 2022.

  • Group One Trading reported no remaining Evoke Pharma position as of Q4 2022 after selling out during the quarter.
  • Group One Trading sold 28 Evoke Pharma shares in Q4 2022, an estimated $1K.
  • Group One Trading first reported a position in Evoke Pharma in Q3 2020 and held it in 8 quarters.
  • Group One Trading's Evoke Pharma position peaked at $89K in Q4 2020.
  • 11 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2022.

Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.